Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for InCarda Therapeutics

    Client Virtual Booth

    INCARDA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    InCarda Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    39899 Balentine Drive, Suite 185 Newark, CA 94560
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://incardatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/incarda-therapeutics
    Twitter
    Twitter
    https://twitter.com/incardathera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    InCarda terminates its PhIII trial for arrhythmia drug
    InCarda terminates its PhIII trial for arrhythmia drug

    https://endpts.com/incarda-terminates-phiii-trial-of-its-inhaled-atrial-fibrillation-drug/

    Kyle LaHucik ENDPTS
    13 Jun 2023
    Share Share
    InCarda, PhysIQ and Syneos team for phase 3 flecainide study
    InCarda, PhysIQ and Syneos team for phase 3 flecainide study

    https://www.fiercebiotech.com/cro/incarda-physiq-and-syneos-team-phase-3-flecainide-study

    Joseph Keenan FIERCEBIOTECH
    31 Aug 2022
    Share Share
    physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health
    physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

    https://www.businesswire.com/news/home/20220824005139/en

    BUSINESSWIRE
    24 Aug 2022
    Share Share
    InCarda Therapeutics Provides Corporate Update
    InCarda Therapeutics Provides Corporate Update

    https://www.biospace.com/article/-incarda-therapeutics-provides-corporate-update-highlighting-new-phase-2-data-for-inrhythm-program-plans-for-pivotal-phase-3-study-and-expansion-of-senior-management-team/

    BIOSPACE
    10 Jun 2021
    Share Share
    InCarda unrolls mid-stage data backing inhaled arrhythmia drug
    InCarda unrolls mid-stage data backing inhaled arrhythmia drug

    https://endpts.com/with-its-eyes-set-on-an-ipo-raise-incarda-preps-to-unroll-mid-stage-data-backing-inhaled-arrhythmia-drug/

    Max Gelman ENDPTS
    09 Jun 2021
    Share Share
    InCarda Therapeutics Provided Corporate Update
    InCarda Therapeutics Provided Corporate Update

    https://www.globenewswire.com/news-release/2021/06/09/2244357/0/en/InCarda-Therapeutics-Provides-Corporate-Update-Highlighting-New-Phase-2-Data-for-InRhythm-Program-Plans-for-Pivotal-Phase-3-Study-and-Expansion-of-Senior-Management-Team.html

    GLOBENEWSWIRE
    09 Jun 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search